There is limited research on the combined effects of smoking and asbestos exposure on risk of localized pleural thickening (LPT). This analysis uses data from the Marysville cohort of workers occupationally exposed to Libby amphibole asbestos (LAA). Workers were interviewed to obtain work and health history, including ever/never smoking and chest X-rays. Cumulative exposure estimates were developed on the basis of fiber measurements from the plant and work history. Benchmark concentration (BMC) methodology was used to evaluate the exposure--response relationship for exposure to LAA and a 10% increased risk of LPT, considering potential confounders and statistical model forms. There were 12 LPT cases among 118 workers in the selected study population. The mean exposure was 0.42 (SD ¼ 0.77) fibers/cc-year, and the prevalence of smoking history was 75.0% among cases and 51.9% among non-cases. When controlling for LAA exposure, smoking history was of borderline statistical significance (P-value ¼ 0.099), and its inclusion improved model fit, as measured by Akaike's Information Criterion. A comparison of BMC estimates was made to gauge the potential effect of smoking status. The BMC was 0.36 fibers/ cc-year, overall. The BMC for non-smokers was approximately three times as high (1.02 fibers/cc-year) as that for the full cohort, whereas the BMC for smokers was about 1/2 that of the full cohort (0.17 fibers/cc-year).
INTRODUCTION
Asbestos exposure and smoking are both known to impact the risk of respiratory disease. The combined effects of asbestos and smoking have been evaluated for certain respiratory outcomes ---for lung cancer, 1 and possibly for asbestosis, 2 the effects of asbestos exposure and smoking combined appear to be greater than effects predicted by additivity. In contrast, smoking does not appear to increase the risk of mesothelioma. 2 However, there have been fewer informative studies evaluating the effects of these two factors together on radiographic abnormalities of the lung and pleura. Radiographic non-cancer abnormalities are of interest because they tend to occur sooner after exposure, compared with asbestosis and other severe outcomes (e.g., lung cancer, mesothelioma), and are irreversible pathological changes associated with decrements in lung function. 3 One example of such a radiographic abnormality is pleural thickening, a condition in which the pleural lining around the lungs (visceral pleura) or along the chest wall and diaphragm (parietal pleura) thicken because of fibrosis and collagen deposits. 3 This thickening may be characterized as either localized pleural thickening (LPT) or diffuse, with diffuse thickening representing an endpoint of greater severity. In the current International Labour Organization (ILO) classification, LPT includes both pleural plaques (focal areas of pleural thickening generally present at the parietal pleura, diaphragm or chest wall) and pleural thickening that does not involve blunting of the costophrenic angle between the rib cage and the diaphragm. 4 LPT is associated with constricting pain 5, 6 and reduced lung function. 7, 8 Libby amphibole asbestos (LAA) is a mixture of amphibole fibers identified in the Rainy Creek complex and present in ore from the vermiculite mine near Libby, MT, USA. 9 Epidemiological studies of worker cohorts in Libby, MT, USA, 10, 11 and Marysville, OH, USA, 12, 13 exposed to LAA fibers indicate increased risk of radiographic abnormalities, and that the latency period for development of radiographic abnormalities may be relatively short (median latency of 8.6 years for pleural plaques in retrospective investigation of serial radiographs). 14 Each of these cohort studies considered smoking in their analytic approach. In the Libby workers cohort, McDonald et al. 11 assessed pleural thickening of the chest wall and found smoking status (current, former, or never smoker) was of borderline statistical significance (P ¼ 0.10) in a regression model, controlling for LAA exposure and age. Amandus et al. 10 also evaluated radiographic abnormalities, constructing separate models for the full cohort, and restricting to current and former smokers. The parameter estimates for LAA exposure were not significant for the two models when controlling for age. In the Marysville workers cohort, smoking was characterized using packyears in the original study, 12 and was significantly associated with risk of all radiographic changes using discriminant analysis. However, results for LPT specifically, or for the effect of smoking controlling for LAA exposure, were not reported. The follow-up study by Rohs et al. 13 did not find a difference in smoking prevalence among those with and without any radiographic changes, but also did not report results for LPT specifically, or controlling for LAA exposure.
Among populations exposed to general asbestos, two studies reported a significant association between risk of all pleural thickening (including both pleural plaques and diffuse pleural thickening, 15 or any pleural abnormality 16 ) and smoking after controlling for some measure of asbestos exposure. A larger number of studies reported borderline ---or possible ---associations when examining risk of pleural changes 17--22 or no association with smoking. 23--27 Possible reasons for the different findings include varying quality of the exposure assessment and the smoking information (some used categories of ever/never or former/current/never, whereas others used pack-years) and differences in the specific outcome studied. For studies that evaluated pleural thickening as an endpoint, it should be noted that the definition of LPT under the ILO classification system has changed over time. Discrete pleural plaques as defined in earlier ILO classification systems have not been associated with smoking in asbestos-exposed workers, 28--30 but there is evidence that asbestosis (small opacities) and diffuse pleural thickening may be associated with smoking in asbestos-exposed individuals. 2, 15 We are not aware of studies that assess the relationship between LPT, as it is currently defined, 4 and any measure of smoking status for LAA or general asbestos. Therefore, this analysis investigates potential for smoking to modify the effect of LAA asbestos exposure on the prevalence of LPT. We used data from the Marysville cohort of workers exposed to LAA to evaluate the effect of smoking on risk of LPT.
METHODS

Study Population
Vermiculite, mined in Libby, MT, USA, and contaminated with LAA, was used in the production of numerous commercial products, including as a potting soil amender and a carrier for pesticides and herbicides. The Marysville cohort includes workers at a Marysville, OH, USA, plant that used Libby vermiculite in the production of fertilizer, beginning around 1960 to 1980. 12 The first study of pulmonary effects in these workers was conducted in 1980 and involved 512 workers who underwent physical examination, spirometry and chest X-rays; trained interviewers gathered information on smoking history, work history at the plant and other relevant work exposures. 12 A follow-up study was conducted in 2002--2005, and included 298 (of the original 512) workers, of which 280 completed the study interview and chest X-ray. 13 As in the original study, workers were interviewed to obtain work and health history, and spirometry, pulmonary examination and chest X-rays were performed. Smoking was self-reported at in-person interview (2004--2005 ) and classified as any smoking history or no smoking history. 13 Three boardcertified radiologists, blinded to any identifying information, independently classified the radiographs using the ILO classification system. 4 The exposure reconstruction in Rohs et al. 13 was updated in this study for all workers in the Marysville, OH, USA, cohort. 13, 31, 32 The update took into account additional industrial hygiene data that were not available for the studies by Rohs et al. 13 or Lockey et al. 12 Exposure estimates up through the year 2000 were developed on the basis of fiber measurements from the plant when available, and estimated fiber concentrations (based on employee interview and later fiber measurements) for the period before industrial hygiene measurements were taken. Using available data on the year of hire and the departments in which each person worked, the cumulative exposure (fibers/cc-year) for each worker for each year since the date of hire was estimated, incorporating seasonal fluctuations in working hours and assuming any exposure off site to be zero. This assumption is likely to be justified, given that the company policy was to launder the employees' work clothes and provide showers for use after work. Each worker's cumulative exposure was then adjusted to a cumulative human equivalent exposure 33 for continuous exposure (CE; fibers/cc-year). In the Marysville cohort, the more accurate exposure data are considered to be those from 1972 and later, as these data were based on analytical measurements, whereas no analytical measurements exist before 1972. Because of the longer follow-up time and additional covariate information, the most informative outcome data come from the 2002 to 2005 examination. To avoid any bias from previous occupational exposure to asbestos, only the data from those who did not report any previous occupational exposure to asbestos were used. Based on these considerations, a sub-cohort of the Marysville workers, which includes data on 118 workers from the 280 workers in the 2002--2005 examination, and who began work in 1972 or later (12 cases of LPT and 106 unaffected individuals), were selected from the full cohort for analysis.
Analysis
Benchmark concentration (BMC) methodology 34 was used to evaluate the exposure--response relationship for exposure to LAA and risk of LPT. In this approach, the available data are fit to a set of mathematical exposure--response models to determine an appropriate empirical representation of the data. General model fit was evaluated using the Hosmer--Lemeshow test, a form of the Pearson's w 2 goodness-of-fit statistic used for dichotomous models. 35 Among models with adequate general fit, the model with the best fit as measured by the Akaike's Information Criterion (AIC; 36 ) was selected. The AIC is a measure of model fit, and a smaller value is considered to reflect better model fit. The BMC is estimated as the exposure level, calculated from the best-fit model, which results in a specified benchmark response. A 10% extra risk is recommended for standard reporting purposes 37 and this value was used in this analysis. All analyses were performed using SAS statistical software v. 9.1.
Dichotomous statistical models (that allow estimation of the background term) describing the probability of individual response as a function of cumulative exposure (represented by CE in units of fibers/ccyear) were used. The candidate mathematical models were 3-parameter log-logistic, dichotomous Hill and dichotomous Michaelis--Menten models (model forms are as follows, where CE ¼ cumulative exposure and g ¼ background rate: 3-parameter log-logistic:
For each of the candidate models, exposure lags of 0, 5, 10, 15 and 20 years were investigated. These lags were chosen to investigate the relative model fit, rather than being based on specific biological considerations. Although we explored models with exposure lagged by 20 years, there were cases of LPT in the Marysville cohort with fewer than 20 years since first exposure; therefore, using such a long lag (which necessitates the assumption that these are background cases) was not judged to be appropriate.
Smoking history was characterized using a ''yes/no'' variable, indicating ever or never smoker. To investigate the key explanatory variables for analysis, a forward-selection process was used to evaluate the association of each of the potential covariates with the risk of LPT, controlling for LAA exposure, in the best-fitting model. Covariates considered for inclusion in the model were time from first exposure, age at X-ray, gender and BMI. Covariates were evaluated according to statistical significance of the covariate, and whether inclusion of the covariate improved model fit as assessed by the AIC.
RESULTS
Characteristics of the study population are presented in Table 1 . The study population comprised 12 cases of LPT and 106 individuals with no radiographic abnormalities. There were 13 women overall (11.0%), of which 1 was an LPT case. Age at X-ray ranged from 42 to 82 years, with a mean of 52 (SD ¼ 7) years, whereas time from first exposure ranged from 23.2 to 32.6 years, with a mean of 28.2 (SD ¼ 2.5) years. Exposure, as characterized by CE, ranged from 0.001 to 5.51 fibers/cc-year, and the mean was 0.42 (SD ¼ 0.77) fibers/cc-year. The prevalence of any smoking history was 54.2% overall, 75.0% (n ¼ 9) among cases and 51.9% (n ¼ 55) among non-cases. Age at X-ray and time from first exposure were similar for non-smokers and smokers (mean ages of 51.2 (SD ¼ 5.8) and 52.5 (SD ¼ 7.9) years, respectively; mean times from first exposure of 28.1 (SD ¼ 2.5) and 28.9 (SD ¼ 2. When controlling for the effect of LAA exposure, there was no association between risk of LPT and time from first exposure (P-value ¼ 0.94), age at X-ray (P-value ¼ 0.82) or gender (P-value ¼ 0.45), and inclusion of each of these covariates increased the AIC. As some workers (n ¼ 21) were missing BMI information, the effect of BMI could not be estimated simultaneously with the background parameter; therefore, the latter was fixed at 1% for this analysis only (P-value for BMI ¼ 0.38). This background value is within the range of previously published estimates of the background incidence of LPT.
38--41 These covariates were not considered in further analyses.
The variable representing smoking history was of borderline statistical significance (P-value ¼ 0.099), and inclusion of this variable (Model 2) decreased the AIC by more than a unit (from 75.2 to 74.0). The following Michaelis--Menten model forms were used for statistical analysis, where CE10 is the cumulative exposure lagged 10 years:
A third model (Model 3) was fit, which added an interaction term between the exposure metric and smoking; in this model, neither the smoking variable by itself nor the interaction term were significant (P-value ¼ 0.230 and 0.582, respectively) and the AIC increased from the base model (AIC of 75.5). The Michaelis--Menten model with exposure lagged by 10 years yielded a BMC of 0.36 fibers/cc-year. Model 2, which includes the smoking variable, was used to derive estimates for smokers and non-smokers separately. A comparison of BMC estimates was made to gauge the potential effect of smoking status. The BMC was derived by setting the beta coefficient for smoking to zero for non-smokers, and to the MLE-estimated value (1.80) for smokers. The BMC for non-smokers was about three times as high as that for the full cohort (1.02 fibers/cc-year), whereas the BMC for smokers was about 1/2 that of the full cohort (0.17 fibers/cc-year).
DISCUSSION
We used data from the Marysville cohort of workers occupationally exposed to LAA to evaluate the joint effects of LAA exposure and smoking on risk of LPT. In the best-fitting model, a variable suggesting an effect of smoking history on increased prevalence of pleural plaques was of borderline statistical significance. We used this model to evaluate how smoking status could potentially affect BMC estimates; the estimated BMC for smokers was approximately six times lower compared with that for nonsmokers, that is, comparable extra risk of health effects for smokers happen at an LAA concentration that is six times lower than that for non-smokers. This difference in the effect of LAA exposure across smoking strata indicates smoking may be an effect modifier of the association between LAA exposure and LPT. A formal test of interaction was not statistically significant, but this may be due to the limited sample size and relatively crude measure of smoking.
It has long been known that smoking impairs clearance of particles from the lung, 42, 43 and animal models indicate that cigarette smoke increases the deposition of asbestos fibers specifically. 44, 45 Therefore, smokers may retain more inhaled asbestos fibers and for a longer period of time, compared with non-smokers, even if both have the same initial exposure. Another possibility is that smoking might affect the timing and progression of LPT development. If LPT develops sooner among smokers compared with non-smokers, this could lead to a higher prevalence of LPT among smokers at a given observation time, and subsequently higher estimated risk.
We evaluated age at X-ray, time from first exposure, gender and BMI as potential covariates, but none of these were significantly associated with risk of LPT after controlling for LAA exposure. It is possible that the age or time from first exposure could act as a proxy for smoking and vice versa, as among smokers, older/longer employed individuals would generally have a longer smoking history. Age is known to be significantly associated with risk of pleural changes even after controlling for LAA exposure 10 ; however, neither age nor time from first exposure were significant here, nor did they improve the model fit as measured by the AIC. This is likely because of the decision to include only those workers hired in 1972 or later, which made workers in the sub-cohort more similar to each other in age and time from first exposure. Therefore, it is unlikely that the possible effects of smoking suggested in this analysis are surrogate for the effect of age or time from first exposure.
There are some limitations to this analysis. First, differing definitions and classifications used for the outcome (discrete pleural plaques or LPT, under different versions of the ILO guidelines) limit the ability to compare these results with those from many previous studies. In this study, the smoking variable was of borderline statistical significance, potentially due to the limited number of individuals in the analysis. Also, we did not have BMI information for all subjects, which limited our ability to evaluate the effect of BMI on risk of LPT. This is an important consideration, as fat pads may be mistaken for pleural thickening on radiographic examination, leading to potential misdiagnosis. 46 There were more analytical exposure measurements available for later years than for the earlier years for the sub-cohort. The lack of detailed smoking information in this cohort (such as packyears) and the relatively small number of non-smokers (only three cases were non-smokers) implies some limitations for the analysis of the effect of smoking on LPT risk among individuals exposed to LAA.
Nevertheless, these analyses suggest that smoking may be an important factor to consider in further studies of LPT among populations exposed to LAA, and potentially, asbestos in general. The BMC (i.e., the level of exposure associated with a 10% extra risk of LPT in this study) estimated separately for smokers (0.17 fibers/cc-year) and non-smokers (1.02 fibers/cc-year) differs by sixfold, which we consider a notable difference. For context, the mean cumulative exposure in the study population was 0.42 fibers/cc-year ---about half of the difference between the two BMC estimates. Further studies using more detailed information on smoking and more sensitive outcome evaluation methods (i.e., high-resolution computed tomography), as well as larger cohorts, should add to our understanding of the interplay between smoking and asbestos exposure on risk of health effects. 
